TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-10 Cr | ₹2.23 Cr | ₹-19 Cr | ₹-0.21 Cr |
What is the latest Cash Flow from Operating Activities ratio of TRIDENT LIFELINE ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-10 Cr |
| Mar2024 | ₹2.23 Cr |
| Mar2023 | ₹-19 Cr |
| Mar2022 | ₹-0.21 Cr |
How is Cash Flow from Operating Activities of TRIDENT LIFELINE Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-10 Cr | Negative | |
| Mar2024 | ₹2.23 Cr | Positive | |
| Mar2023 | ₹-19 Cr | Negative | |
| Mar2022 | ₹-0.21 Cr | - | |
Compare Cash Flow from Operating Activities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹293.3 Cr | -0.9% | -2.8% | -2.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,036.0 Cr | 0.8% | -4.2% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,218.0 Cr | 1.1% | -0.7% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,099.0 Cr | 0% | 1.3% | 40.1% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | -0.3% | -4.1% | -8.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.4% | -4.5% | -5.2% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -0.9% |
-2.8% |
-2.4% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses